For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Enzyme-Linked Immunosorbent Assay (ELISA) Testing market revenue was 429.97 Million USD in 2022, and will reach 645.63 Million USD in 2028, with a CAGR of 7.01% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing industry, and breaks down according to the type, application, and consumption area of Enzyme-Linked Immunosorbent Assay (ELISA) Testing. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Enzyme-Linked Immunosorbent Assay (ELISA) Testing in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) Testing market covered in Chapter 11:
QIAGEN NV
Merck KGaA
Agilent Technologies Inc.
Abcam Plc
Bio-Rad Laboratories Inc.
Dickinson and Co.
F. Hoffmann-La Roche Ltd.
PerkinElmer Inc.
Becton
bioMérieux SA
Thermo Fisher Scientific Inc.
In Chapter 3, on the basis of types, the Enzyme-Linked Immunosorbent Assay (ELISA) Testing market from 2018 to 2028 is primarily split into:
Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA
In Chapter 4, on the basis of applications, the Enzyme-Linked Immunosorbent Assay (ELISA) Testing market from 2018 to 2028 covers:
Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring & Pharmaceutical Industry
Transplantation
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028